» Articles » PMID: 38239817

Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features Up to 2 Years

Overview
Journal Neurol Genet
Date 2024 Jan 19
PMID 38239817
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The objective of this case report was to describe the first report of variants associated with adult-onset paucisymptomatic leukoencephalopathy associated with cerebral folate deficiency (CFD).

Methods: Considering the patient's symptoms, a nonprogressive leukoencephalopathy was suspected. CSF 5-methyltetrahydrofolate levels were low (10 nmol/L, normal range 41-117). With no other identifiable causes, a genetic analysis was conducted, revealing a compound heterozygous variation (c.45G>T and c. 493+2T>C).

Results: A 47-year-old man with a history of drug and alcohol abuse was admitted to the hospital for double vision and postural instability. MRI of the brain was performed, which showed bilateral leukoencephalopathy. Diffusion tensor imaging revealed a diffuse reduction in fractional anisotropy, suggesting microstructural changes. MRI of the brain and overall clinical picture were stable on subsequent serial examinations.

Discussion: Scientific evidence supports the deleterious effect of c.45G>T and c.493+2T>C variations on the folate receptor-α (FRα) protein structure and function. The weakness of the expression and function of FRα without elimination of its function caused by specific compound heterozygous variations may explain the atypical features observed in our patient. Although rare, CFD should be considered in paucisymptomatic adult patients with stable diffuse MRI white matter changes.

Citing Articles

Erratum: Missing Full Disclosures.

Neurol Genet. 2024; 10(6):e200218.

PMID: 39512793 PMC: 11543267. DOI: 10.1212/NXG.0000000000200218.

References
1.
Ramaekers V, Segers K, Sequeira J, Koenig M, Van Maldergem L, Bours V . Genetic assessment and folate receptor autoantibodies in infantile-onset cerebral folate deficiency (CFD) syndrome. Mol Genet Metab. 2018; 124(1):87-93. DOI: 10.1016/j.ymgme.2018.03.001. View

2.
Grapp M, Just I, Linnankivi T, Wolf P, Lucke T, Hausler M . Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain. 2012; 135(Pt 7):2022-31. DOI: 10.1093/brain/aws122. View

3.
Ramaekers V, Quadros E . Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies. Nutrients. 2022; 14(15). PMC: 9370123. DOI: 10.3390/nu14153096. View

4.
Spector R, Johanson C . Vectorial ligand transport through mammalian choroid plexus. Pharm Res. 2010; 27(10):2054-62. DOI: 10.1007/s11095-010-0162-2. View

5.
Hyland K, Shoffner J, Heales S . Cerebral folate deficiency. J Inherit Metab Dis. 2010; 33(5):563-70. DOI: 10.1007/s10545-010-9159-6. View